Your Search for 'Cardiac Toxicity' returned 72 results - Page 1 of 4

• Cardiotoxicity of Non-Cardiovascular Drugs

  EURO€ 119.00USD$ 155.00GBP£ 100.00AUD$ 151.00JPY¥ 15,267.00SEK 1 015,00CHF 146.00CAD$ 158.00 John Wiley and Sons Ltd, Apr 2010 , Pages: 360
  major forms of toxicity seen in drugs and it accounts for most drug recalls and delays experienced in regulatory approvals.In recent years a number of non-cardiac blockbuster drugs such as terfenadine ...

• Nitric Oxide - Therapeutics, Markets and Companies

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 Jain PharmaBiotech, May 2013 , Pages: 276
  NO Role of NO in the cardiovascular system NO and atrial natriuretic peptide NOS in the cardiac myocyte NO and the autonomic control of the heart rate NO and vasodilatation NO and blood pressure ...

• MicroRNAs and Exosomes Market Report 2012

  EURO€ 1,600.00USD$ 2,082.00GBP£ 1,346.00AUD$ 2,036.00JPY¥ 205,518.00SEK 13 667,00CHF 1'962.00CAD$ 2,121.00 Select Biosciences Ltd, Aug 2012 , Pages: 168
  Disease, Inflammation and Angiogenesis - microRNAs Associated with Cardiac Hypertrophy - Diabetes - CNS Normal Development and Diseases - Stem Cells - Hepatic Physiology, Pathology, and Toxicity Screening ...

• Cell Therapy - Technologies, Markets and Companies

  EURO€ 4,228.00USD$ 5,500.00GBP£ 3,557.00AUD$ 5,379.00JPY¥ 543,031.00SEK 36 112,00CHF 5'184.00CAD$ 5,604.00 Jain PharmaBiotech, May 2013 , Pages: 1050
  system and cancer which are the topics for separate chapters. Other applications include cardiac disorders (myocardial infarction and heart failure), diabetes mellitus, diseases of bones and joints ...

• Nanobiotechnology Applications, Markets and Companies

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 771
  myocardial infarction in saliva by a nanobiochip Nanobiosensors for detection of cardiovascular disorders Use of magnetic NPs as MRI contrast agents for cardiac imaging Perfluorocarbon NPs for combining ...

• The AH Receptor in Biology and Toxicology

  EURO€ 119.00USD$ 155.00GBP£ 100.00AUD$ 151.00JPY¥ 15,267.00SEK 1 015,00CHF 146.00CAD$ 158.00 John Wiley and Sons Ltd, Jan 2012 , Pages: 552
  includes epigenetic mechanisms, gene expression, reproductive and developmental toxicity, signal transduction, and transgenic animal models. Featuring an internationally recognized team of authors at the ...

• Singulex, Inc. - Product Pipeline Analysis

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 GlobalData, Nov 2012 , Pages: 26
  treatment of inflammation, cardiovascular, neurology, oncology, metabolism and toxicity. Singulex is headquartered in Alameda, California, the US. This report is a source for data, analysis and actionable ...

• Target Organ Toxicity, Volumes I and II

  EURO€ 438.00USD$ 570.00GBP£ 369.00AUD$ 558.00JPY¥ 56,278.00SEK 3 743,00CHF 537.00CAD$ 581.00 Informa Healthcare, Jan 1999
  Organ for Toxicity. Index. 240 pp., 7x10, 1986. VOLUME II: Kidney as a Target Organ for Toxicity. Cardiac Toxicity. Lung as a Target Organ for Toxicity. Target Organ Toxicity: Male Reproductive ...

• Muscle 2-Volume Set

  EURO€ 143.00USD$ 186.00GBP£ 120.00AUD$ 182.00JPY¥ 18,368.00SEK 1 222,00CHF 175.00CAD$ 190.00 Elsevier Science and Technology, Aug 2012 , Pages: 1528
  state-of-the-art insights into the three forms of muscle--cardiac, skeletal, and smooth--from molecular anatomy, basic physiology, disease mechanisms, and targets of therapy. Commonalities and contrasts ...

• 10 - 2012 Emerging Medical Technologies Spotlight: A Report Of Investment & Partnering Opportunities

  EURO€ 153.00USD$ 199.00GBP£ 129.00AUD$ 195.00JPY¥ 19,648.00SEK 1 307,00CHF 188.00CAD$ 203.00 Life Science Intelligence, Oct 2012 , Pages: 10
  previously unseen levels of speed, sensitivity, and specificity - 3D cell-based assays to create better in vitro prediction of complex biochemical responses, with a focus on evaluation of drug toxicity and ...

• Cellular response to biomaterials

  EURO€ 220.00USD$ 286.00GBP£ 185.00AUD$ 280.00JPY¥ 28,245.00SEK 1 878,00CHF 270.00CAD$ 292.00 Woodhead Publishing Ltd, Dec 2008 , Pages: 648
  biocompatible coating in orthopaedic and cardiac medicine. Part 3 The effect of surfaces and proteins on cell response: Cell response to nanofeatures in biomaterials - Cell response to surface chemistry in ...

• Therapeutic Drug Monitoring - Technologies, Markets, and Companies

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 Jain PharmaBiotech, May 2013 , Pages: 169
  metabonomic data to develop toxicity biomarkers Toxicology studies based on biomarkers Biomarkers of hepatotoxicity Biomarkers of nephrotoxicity Cardiotoxicity Neurotoxicity Biomarkers in clinical trials ...

• Neuroprotection - Drugs, Markets and Companies

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 665
  Dehydroascorbic acid Tocotrienols Uric acid Antiglutamate compounds MRZ 2/576 L-Phenylalanine Arimoclomol for stroke Cardiac glycosides as neuroprotectives in stroke Clenbuterol Coagulation inhibitors as ...

• General and Applied Toxicology, 6 Volume Set, 3rd Edition

  EURO€ 1,183.00USD$ 1,539.00GBP£ 995.00AUD$ 1,505.00JPY¥ 151,911.00SEK 10 102,00CHF 1'450.00CAD$ 1,568.00 John Wiley and Sons Ltd, Oct 2009 , Pages: 3490
  Dubakiene). 56 Ototoxicity (Andrew Forge, Ruth Taylor and Ernest S. Harpur). 57 Cardiac Toxicology (Lalita A. Bharadwaj). 58 Cardiac Toxicity of Anthracyclines (Richard D. Olson and Barry J. Cusack ...

• Comparative Pathophysiology and Toxicology of Cyclooxygenases

  EURO€ 108.00USD$ 140.00GBP£ 90.00AUD$ 137.00JPY¥ 13,817.00SEK 919,00CHF 132.00CAD$ 143.00 John Wiley and Sons Ltd, Oct 2012 , Pages: 336
  Comparative Pathophysiology and Toxicology of Cyclooxygenases The first thorough review of cyclooxygenase inhibitors, including their toxicity mechanisms and toxicopathological risks ...

• NewCardio, Inc. (NWCI) - Product Pipeline Analysis

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 GlobalData, Oct 2011 , Pages: 31
  acute and chronic heart disease. The company's cardiac diagnostic products and services are used to determine the cardiac toxicity and also for evaluating cardiac safety of new drugs. This report is a ...

• Personalized Medicine - Scientific and Commercial Aspects

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 854
  in drug safety Adverse drug reactions Adverse drug reactions in children Adverse drug reactions related to toxicity of chemotherapy Genetically determined adverse drug reactions Malignant ...

• ADMET for Medicinal Chemists. A Practical Guide

  EURO€ 102.00USD$ 133.00GBP£ 86.00AUD$ 130.00JPY¥ 13,122.00SEK 873,00CHF 125.00CAD$ 135.00 John Wiley and Sons Ltd, Feb 2011 , Pages: 512
  . 5.6 PK Practices. 5.7 Engineering Molecules with Desired ADME Profile. 6 Cardiac Toxicity (Ralf Kettenhofen and Silke Schwengberg). 6.1 Introduction. 6.2 Ion Channel-Related Cardiac Toxicity ...

• Gene Therapy - Technologies, Markets and Companies

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 665
  heart disease Congestive heart failure Rationale of gene therapy in CHF AAV-mediated gene transfer for CHF AngioCell gene therapy for CHF ß-ARKct gene therapy Elevating cardiac dATP by gene therapy ...

• How to Survive in Anaesthesia. 4th Edition

  EURO€ 47.00USD$ 61.00GBP£ 40.00AUD$ 60.00JPY¥ 6,031.00SEK 401,00CHF 58.00CAD$ 62.00 John Wiley and Sons Ltd, Nov 2011 , Pages: 256
  features for this edition include: - A new introduction on the theatre environment - A new chapter on local anaesthetic toxicity - The latest guidelines on intravenous fluids - Updated ...